Bidea Llc

BIDEA LLC is an NSF SBIR Phase I start-up company founded in May 2016 by four scientists. At BIDEA LLC, our aim is to develop an effective point-of-care (POC) In-vitro Diagnostic Device (IVDD) for the early detection of endometrial cancer. This test will not only impact the quality of live of patients, but can also reduce costs to hospitals, health insurances companies and government agencies. The proposed screening technology is expected to help gynecologists in hospitals and in private practices provide a complete diagnosis in less time, reducing the number of visits and endometrial cancer incidence through early detection, especially in women over the age of 50. Our vision is to improve the quality of live of women patients by providing an innovative and affordable solution for the early detection of endometrial cancer. Our mission is to develop an innovative Endometrial Cancer Monitoring System (ECMS) to provide doctors and women immediate screening for the early detection of endometrial cancer.